Total Cardiovascular Risk Management

American Journal of Cardiology

Volumn 100, Issue 3 SUPPL., 2007, Pages

  Ritz, Eberhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE REGULATION; BORDERLINE HYPERTENSION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; DIET THERAPY; DYSLIPIDEMIA; EXERCISE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; LONG TERM CARE; META ANALYSIS; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SMOKING CESSATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CARDIOVASCULAR DISEASES; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; RISK MANAGEMENT;

EID: 34547133981     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.05.015     Document Type: Article

References (52)

1. MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., Abbott R., Godwin J., Dyer A.J., and Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335 (1990) 765-774
2. Neal B., MacMahon S., and Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 356 (2000) 1955-1964
3. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., Jones D.W., Materson B.J., Oparil S., Wright Jr. J.T., Roccella E.J., National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and and Treatment of High Blood Pressure and the National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 289 (2003) 2560-2572
4. De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J., Ebrahim S., Faergeman O., Graham I., Mancia G., et al., European Society of Cardiology Committee for Practice Guidelines. European guidelines on cardiovascular disease prevention in clinical practice: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil 10 (2003) S1-S10
5. Guidelines Committee 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21 (2003) 1011-1053
6. Whitworth J.A., and World Health Organization International Society of Hypertension Writing Group 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21 (2003) 1983-1992
7. Gasse C., Hense H.W., Stieber J., Doring A., Liese A.D., and Keil U. Assessing hypertension management in the community: trends of prevalence, detection, treatment, and control of hypertension in the MONICA Project, Augsburg 1984-1995. J Hum Hypertens 15 (2001) 27-36
8. Pavlik V.N., and Hyman D.J. How well are we managing and monitoring high blood pressure?. Curr Opin Nephrol Hypertens 12 (2003) 299-304
9. Primatesta P., and Poulter N.R. Improvement in hypertension management in England: results from the Health Survey for England 2003. J Hypertens 24 (2006) 1193-1200
10. Lindholm L.H. The problem of uncontrolled hypertension. J Hum Hypertens 16 suppl 3 (2002) S3-S8
11. Poggi L., Chamontin B., Lang T., Menard J., Chevalier H., Gallois H., and Cremier O. Prevalence, treatment and control of hypertension in family practice patients in France during 1994. [in French]. Arch Mal Coeur Vaiss 89 (1996) 1075-1080
12. Khan N., Chockalingam A., and Campbell N.R. Lack of control of high blood pressure and treatment recommendations in Canada. Can J Cardiol 18 (2002) 657-661
13. Mancia G., Parati G., Borghi C., Ghironzi G., Andriani E., Marinelli L., Valentini M., Tessari F., Ambrosiani E., and SMOOTH investigators. Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study. J Hypertens 24 (2006) 837-843
14. Prevost G., Phan T.M., Mounier-Vehier C., and Fontaine P. Control of cardiovascular risk factors in patients with type 2 diabetes and hypertension in a French national study (Phenomen). Diabetes Metab 31 (2005) 479-485
15. Saydah S.H., Fradkin J., and Cowie C.C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291 (2004) 335-342
16. Lenfant C. Clinical research to clinical practice-lost in translation?. N Engl J Med 349 (2003) 868-874
17. Anderson K.M., Odell P.M., Wilson P.W., and Kannel W.B. Cardiovascular disease risk profiles. Am Heart J 121 (1991) 293-298
18. Vasan R.S., Larson M.G., Leip E.P., Evans J.C., O'Donnell C.J., Kannel W.B., and Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 345 (2001) 1291-1297
19. Kshirsagar A.V., Carpenter M., Bang H., Wyatt S.B., and Colindres R.E. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med 119 (2006) 133-141
20. Hsu C.Y., McCulloch C.E., Darbinian J., Go A.S., and Iribarren C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 165 (2005) 923-928
21. Benjamin S.M., Valdez R., Geiss L.S., Rolka D.B., and Narayan K.M. Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diabetes Care 26 (2003) 645-649
22. Zhang Y., Lee E.T., Devereux R.B., Yeh J., Best L.G., Fabsitz R.R., and Howard B.V. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension 47 (2006) 410-414
23. Borch-Johnsen K., Feldt-Rasmussen B., Strandgaard S., Schroll M., and Jensen J.S. Urinary albumin excretion: an independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 19 (1999) 1992-1997
24. Brantsma A.H., Bakker S.J., de Zeeuw D., de Jong P.E., and Gansevoort R.T. Urinary albumin excretion as a predictor of the development of hypertension in the general population. J Am Soc Nephrol 17 (2006) 331-335
25. World Health Organization. Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications: report of a WHO Consultation (1999), World Health Organisation, Geneva
26. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
27. Kylin E. Studies of the hypertension-hyperglycemia-hyperuricemia syndrome [in German]. Zentralblatt für Innere Medizin 44 (1923) 105-127
28. Kahn R., Buse J., Ferrannini E., Stern M., and American Diabetes Association and the European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 48 (2005) 1684-1699
29. Ford E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28 (2005) 1769-1778
30. Sundström J., Riserus U., Byberg L., Zethelius B., Lithell H., and Lind L. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ 332 (2006) 878-882
31. Hunt K.J., Resendez R.G., Williams K., Haffner S.M., Stern M.P., and San Antonio Heart Study. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110 (2004) 1251-1257
32. Wong T.Y., Duncan B.B., Golden S.H., Klein R., Couper D.J., Klein B.E.K., Hubbard L.D., Sharrett A.R., and Schmidt M.I. Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk In Communities study. Invest Ophthalmol Vis Sci 45 (2004) 2949-2954
33. Golden S.H., Folsom A.R., Coresh J., Sharrett A.R., Szklo M., and Brancati F. Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the Atherosclerosis Risk In Communities study. Diabetes 51 (2002) 3069-3076
34. Schillaci G., Pirro M., Vaudo G., Mannarino M.R., Savarese G., Pucci G., Franklin S.S., and Mannarino E. Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension 45 (2005) 1078-1082
35. Schillaci G., Pirro M., Vaudo G., Gemelli F., Marchesi S., Porcellati C., and Mandarino E. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 43 (2004) 1817-1822
36. Mancia G., Facchetti R., Bombelli M., Friz H.P., Grassi G., Giannattasio C., and Sega R. Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population. Hypertension 45 (2005) 1072-1077
37. Mulè G., Nardi E., Cottone S., Cusimano P., Volpe V., Piazza G., Mongiovì R., Mezzatesta G., Andronico G., and Cerasola G. Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med 257 (2005) 503-513
38. Barker D.J., Osmond C., Forsen T.J., Kajantie E., and Eriksson J.G. Trajectories of growth among children who have coronary events as adults. N Engl J Med 353 (2005) 1802-1809
39. Bhargava S.K., Sachdev H.S., Fall C.H., Osmond C., Lakshmy R., Barker D.J.P., Biswas S.K.D., Ramji S., Prabhakaran D., and Reddy K.S. Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med 350 (2004) 865-875
40. Brenner B.M., Garcia D.L., and Anderson S. Glomeruli and blood pressure: less of one, more of the other?. Am J Hypertens 1 (1988) 335-347
41. Keller G., Zimmer G., Mall G., Ritz E., and Amann K. Nephron number in patients with primary hypertension. N Engl J Med 348 (2003) 101-108
42. Gross M.L., Amann K., and Ritz E. Nephron number and renal risk in hypertension and diabetes. J Am Soc Nephrol 16 suppl 1 (2005) S27-S29
43. Hoy W.E., Hughson M.D., Singh G.R., Douglas-Denton R., and Bertram J.F. Reduced nephron number and glomerulomegaly in Australian Aborigines: a group at high risk for renal disease and hypertension. Kidney Int 70 (2006) 104-110
44. Laufs U., Werner N., Link A., Endres M., Wassmann S., Jurgens K., Miche E., Böhm M., and Nickenig G. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 109 (2004) 220-226
45. Laufs U., Wassmann S., Czech T., Munzel T., Eisenhauer M., Bohm M., and Nickenig G. Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis. Arterioscler Thromb Vasc Biol 25 (2005) 809-814
46. Mancia G., and Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens 20 (2002) 1461-1464
47. Pechere-Bertschi A., Greminger P., Hess L., Philippe J., and Ferrari P. Swiss Hypertension and Risk Factor Program (SHARP): cardiovascular risk factors management in patients with type 2 diabetes in Switzerland. Blood Press 14 (2005) 337-344
48. Grandi A.M., Maresca A.M., Sessa A., Stella R., Ponti D., Barlocco E., Banfi F., and Venco A. Longitudinal study on hypertension control in primary care: the Insubria study. Am J Hypertens 19 (2006) 140-145
49. Okonofua E.C., Simpson K.N., Jesri A., Rehman S.U., Durkalski V.L., and Egan B.M. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension 47 (2006) 345-351
50. Bakris G.L., Williams M., Dworkin L., Elliot W.J., Epstein M., Toto R., Tuttle K., Douglas J., Hsueh W., Sowers J., and National Kidney Foundation hypertension and Diabetes Executive Committees Working Group. Preserving renal function in adults with hypertension and diabetes: a consensus approach. Am J Kidney Dis 36 (2000) 646-661
51. Schwenger V., and Ritz E. Audit of antihypertensive treatment in patients with renal failure. Nephrol Dial Transplant 13 (1998) 3091-3095
52. Gaede P., Vedel P., Larsen N., Jensen G.V., Parving H.H., and Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348 (2003) 383-393